BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38082255)

  • 1. Remote at-home wearable-based gait assessments in Progressive Supranuclear Palsy compared to Parkinson's Disease.
    Sharma M; Mishra RK; Hall AJ; Casado J; Cole R; Nunes AS; Barchard G; Vaziri A; Pantelyat A; Wills AM
    BMC Neurol; 2023 Dec; 23(1):434. PubMed ID: 38082255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing speech analysis to differentiate progressive supranuclear palsy from Parkinson's disease.
    Kang K; Nunes AS; Sharma M; Hall AJ; Mishra RK; Casado J; Cole R; Derhammer M; Barchard G; Najafi B; Vaziri A; Wills AM; Pantelyat A
    Parkinsonism Relat Disord; 2023 Oct; 115():105835. PubMed ID: 37678101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning.
    De Vos M; Prince J; Buchanan T; FitzGerald JJ; Antoniades CA
    Gait Posture; 2020 Mar; 77():257-263. PubMed ID: 32078894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy.
    Abate F; Russo M; Ricciardi C; Tepedino MF; Romano M; Erro R; Pellecchia MT; Amboni M; Barone P; Picillo M
    Parkinsonism Relat Disord; 2023 Apr; 109():105345. PubMed ID: 36868037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminating features of gait performance in progressive supranuclear palsy.
    Amano S; Skinner JW; Lee HK; Stegemöller EL; Hack N; Akbar U; Vaillancourt D; McFarland NR; Hass CJ
    Parkinsonism Relat Disord; 2015 Aug; 21(8):888-93. PubMed ID: 26032992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
    Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages.
    Amboni M; Ricciardi C; Picillo M; De Santis C; Ricciardelli G; Abate F; Tepedino MF; D'Addio G; Cesarelli G; Volpe G; Calabrese MC; Cesarelli M; Barone P
    Sci Rep; 2021 Apr; 11(1):9297. PubMed ID: 33927317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
    Ondo W; Warrior D; Overby A; Calmes J; Hendersen N; Olson S; Jankovic J
    Arch Neurol; 2000 Oct; 57(10):1464-9. PubMed ID: 11030799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis between Parkinson's disease and atypical parkinsonism based on gait and postural instability: Artificial intelligence using an enhanced weight voting ensemble model.
    Song J; Kim J; Lee MJ; Ahn JH; Lee DY; Youn J; Chung MJ; Kim Z; Cho JW
    Parkinsonism Relat Disord; 2022 May; 98():32-37. PubMed ID: 35447488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Relevance of Standardized Mobile Gait Tests. Reliability Analysis Between Gait Recordings at Hospital and Home in Parkinson's Disease: A Pilot Study.
    Gaßner H; Sanders P; Dietrich A; Marxreiter F; Eskofier BM; Winkler J; Klucken J
    J Parkinsons Dis; 2020; 10(4):1763-1773. PubMed ID: 32925099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balance telerehabilitation and wearable technology for people with Parkinson's disease (TelePD trial).
    Silva-Batista C; Wilhelm JL; Scanlan KT; Stojak M; Carlson-Kuhta P; Chen S; Liu W; de la Huerta TNG; Horak FB; Mancini M; King LA
    BMC Neurol; 2023 Oct; 23(1):368. PubMed ID: 37833645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional limits of stability and standing balance in people with Parkinson's disease with and without freezing of gait using wearable sensors.
    Hasegawa N; Maas KC; Shah VV; Carlson-Kuhta P; Nutt JG; Horak FB; Asaka T; Mancini M
    Gait Posture; 2021 Jun; 87():123-129. PubMed ID: 33906091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogates for rigidity and PIGD MDS-UPDRS subscores using wearable sensors.
    Safarpour D; Dale ML; Shah VV; Talman L; Carlson-Kuhta P; Horak FB; Mancini M
    Gait Posture; 2022 Jan; 91():186-191. PubMed ID: 34736096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Monitoring of Progressive Supranuclear Palsy using Body-Worn Movement Sensors.
    Sotirakis C; Conway N; Su Z; Villarroel M; Tarassenko L; FitzGerald JJ; Antoniades CA
    Mov Disord; 2022 Nov; 37(11):2263-2271. PubMed ID: 36054142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.
    Hill EJ; Mangleburg CG; Alfradique-Dunham I; Ripperger B; Stillwell A; Saade H; Rao S; Fagbongbe O; von Coelln R; Tarakad A; Hunter C; Dawe RJ; Jankovic J; Shulman LM; Buchman AS; Shulman JM
    Parkinsonism Relat Disord; 2021 Mar; 84():105-111. PubMed ID: 33607526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.
    Bottero V; Santiago JA; Potashkin JA
    J Parkinsons Dis; 2018; 8(4):529-537. PubMed ID: 30248063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-based motor assessment of Parkinson's disease using postural sway, gait and lifestyle features on crowdsourced smartphone data.
    Abujrida H; Agu E; Pahlavan K
    Biomed Phys Eng Express; 2020 Mar; 6(3):035005. PubMed ID: 33438650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.